Found: 7
Select item for more details and to access through your institution.
Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Chinese Subjects.
- Published in:
- Clinical Drug Investigation, 2014, v. 34, n. 11, p. 763, doi. 10.1007/s40261-014-0230-1
- By:
- Publication type:
- Article
Anti-Oxidative Stress Effect of Loading-Dose Rosuvastatin Prior to Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: A Prospective Randomized Controlled Clinical Trial.
- Published in:
- Clinical Drug Investigation, 2014, v. 34, n. 11, p. 773, doi. 10.1007/s40261-014-0231-0
- By:
- Publication type:
- Article
Quality of Life in Patients with Irritable Bowel Syndrome (IBS), Assessed Using the IBS-Quality of Life (IBS-QOL) Measure After 4 and 8 Weeks of Treatment with Mebeverine Hydrochloride or Pinaverium Bromide: Results of an International Prospective Observational Cohort Study in Poland, Egypt, Mexico and China
- Published in:
- Clinical Drug Investigation, 2014, v. 34, n. 11, p. 783, doi. 10.1007/s40261-014-0233-y
- By:
- Publication type:
- Article
Steady-State Bioavailability of Extended-Release Methylphenidate (MPH-MLR) Capsule vs. Immediate-Release Methylphenidate Tablets in Healthy Adult Volunteers.
- Published in:
- Clinical Drug Investigation, 2014, v. 34, n. 11, p. 795, doi. 10.1007/s40261-014-0234-x
- By:
- Publication type:
- Article
A New Reversible and Potent P2Y Receptor Antagonist (ACT-246475): Tolerability, Pharmacokinetics, and Pharmacodynamics in a First-in-Man Trial.
- Published in:
- Clinical Drug Investigation, 2014, v. 34, n. 11, p. 807, doi. 10.1007/s40261-014-0236-8
- By:
- Publication type:
- Article
Levetiracetam Pharmacokinetics in Japanese Subjects with Renal Impairment.
- Published in:
- Clinical Drug Investigation, 2014, v. 34, n. 11, p. 819, doi. 10.1007/s40261-014-0237-7
- By:
- Publication type:
- Article
Initial 3-Weeks' Apixaban Versus Dual-Antiplatelet Therapy (Clopidogrel and Aspirin) Followed by Clopidogrel Alone in High-Risk Patients with Acute Non-Disabling Cerebrovascular Events (ADANCE): Study Protocol for a Randomized Controlled Trial.
- Published in:
- Clinical Drug Investigation, 2014, v. 34, n. 11, p. 755, doi. 10.1007/s40261-014-0228-8
- By:
- Publication type:
- Article